key: cord-1046255-c3xhos4t
authors: Zhu, Jocelyn S; Ge, Peilin; Jiang, Chunguo; Zhang, Yong; Li, Xiaoran; Zhao, Zirun; Zhang, Liming; Duong, Tim Q
title: Deep‐learning artificial intelligence analysis of clinical variables predicts mortality in COVID‐19 patients
date: 2020-07-16
journal: J Am Coll Emerg Physicians Open
DOI: 10.1002/emp2.12205
sha: d57d8e2aa1593c2fec13b5dd727a9c604ae54c64
doc_id: 1046255
cord_uid: c3xhos4t

STUDY OBJECTIVE: The large number of clinical variables associated with coronavirus disease 2019 (COVID‐19) infection makes it challenging for frontline physicians to effectively triage COVID‐19 patients during the pandemic. This study aimed to develop an efficient deep‐learning artificial intelligence algorithm to identify top clinical variable predictors and derive a risk stratification score system to help clinicians triage COVID‐19 patients. METHODS: This retrospective study consisted of 181 hospitalized patients with confirmed COVID‐19 infection from January 29, 2020 to March 21, 2020 from a major hospital in Wuhan, China. The primary outcome was mortality. Demographics, comorbidities, vital signs, symptoms, and laboratory tests were collected at initial presentation, totaling 78 clinical variables. A deep‐learning algorithm and a risk stratification score system were developed to predict mortality. Data were split into 85% training and 15% testing. Prediction performance were compared with those using COVID‐19 severity score, CURB‐65 score and pneumonia severity index (PSI). RESULTS: Of the 181 COVID‐19 patients, 39 expired and 142 survived. Five top predictors of mortality were D‐dimer, O(2) Index, neutrophil:lymphocyte ratio, C‐reactive protein, and lactate dehydrogenase. The top 5 predictors and the resultant risk score yielded, respectively, an area under curve (AUC) of 0.968 ([95% CI:0.87‐1.0]) and 0.954 ([95% CI:0.80‐0.99]) for the testing dataset. Our models outperformed COVID‐19 severity score (AUC = 0.756), CURB‐65 score (AUC = 0.671), and PSI (AUC = 0.838). The mortality rates for our risk stratification scores (0‐5) were 0, 0, 6.7, 18.2, 67.7, and 83.3%, respectively. CONCLUSIONS AND RELEVANCE: Deep‐learning prediction model and the resultant risk stratification score may prove useful in clinical decision‐making under time‐sensitive and resource‐constrained environment. This article is protected by copyright. All rights reserved

The coronavirus disease 2019 (COVID-19) that causes severe respiratory illnesswas first reported in Wuhan, China in December 2019 [1] [2] [3] and was declared a pandemic by the World Health Organization on March 11, 2020. 4 More than 4.2 million people have been infected and more than 290,000 have died of COVID-19 worldwide (May 11, 2020). 5 The actual numbers are likely much higher due to testing shortages and under reporting. There are likely to be second waves and recurrence. 6 The current COVID-19 pandemic has overwhelmed many hospitals around the world.

There is an urgent need by frontline physicians to effectively triage patients under timesensitive, stressful, and potentially resource-constrained circumstances in this COVID-19 pandemic. This is particularly challenging in light of the large array of clinical variables that have been identified to be associated with COVID-19 infection, while the disease course remains incompletely understood and effective treatments are not yet available. The most commonly used reverse-transcriptase polymerase chain reaction (RT-PCR) has poor sensitivity (high false-negative rate 7 ) and long turnaround time (a few days to a week 8 ) during which the patients are assumed COVID-19 positive, potentially holding up valuable resources. Moreover, there are heterogeneous symptom presentations and many patients are asymptomatic but may deteriorate rapidly. [1] [2] [3] Given these challenges, establishing a simplified risk stratification score system from studying the large array of clinical variables from large cohorts of patients could be helpful in COVID-19 disease management. Similar risk stratification scores, such as Sequential Organ Failure Assessment (SOFA) and Modified Early Warning Score (MEWS), have been established for general emergency room triage. Unfortunately, SOFA and MEWS are not very helpful as they failed to accurately stratify COVID-19 patients. [9] [10] [11] Machine learning methods are increasingly being used in medicine. [12] [13] [14] Machine learning employs computer algorithms to learn relationships amongst different data elements to inform outcomes. In contrast to conventional analysis methods (such as linear or logistic regression), the exact relationship amongst different data elements with respect to outcome variables does not need to be explicitly specified. The neural network method in machine learning for example is made up of a collection of connected nodes, which models the neurons in a biological brain. Each connection, like the synapses in a brain, can transmit signals to and receive signals from other nodes. Nodes and connections are initialized with weights which are adjusted during learning. In radiology, machine learning has been shown to be able to accurately detect lung nodules on chest X-rays after it learns from a separate training dataset constructed with expert radiologist labels of nodules. 15 In cardiology, machine learning has been shown to be able to detect abnormal EKG patterns after it learns from a separate training dataset constructed with expert cardiologist labels of normal and abnormal EKGs. 16 Machine learning has also been used to estimate risk, such as in the Framingham Risk Score for coronary heart disease, 17 and to guide antithrombotic therapy in atrial fibrillation 18 and defibrillator implantation in hypertrophic cardiomyopathy. 19 In addition to approximating physician skills, machine learning alogrithms can also find novel relationships not readily apparent to humans. Many studies have shown that machine learning outperforms logistic regression and classification tree models 20 as well as humans in many tasks in medicine. 21 Machine learning is particularly useful in dealing with large and complex datasets. With increasing computing power and growing relevance of big data in medicine, machine learning is expected to play an important role in clinical practice.

The goal of this study was to develop a deep-learning artificial intelligence algorithm to identify the top predictors amongst the large array of clinical variables at admission to predict the likelihood of mortality in COVID-19 patients. Based on these deep-learning findings we developed a simplified risk stratification score system to predict the likelihood of mortality. Prediction performance was compared with those obtained using standard CURB-65 score for pneumonia infection, pneumonia severity index (PSI), and COVID-19 severity score. Preprocessing: A few patients had some missing clinical variables. The clinical variable (brain natriuretic peptide) was missing from >15% of the patients were removed from the dataset. For others where needed, missing data were imputed with predictive mean modeling using the Multivariate Imputation by Chained Equations in R (statistical analysis software 4.0). 24 The majority of the parameters had <5% missing data. Collinearity analysis in feature selection was used to remove correlated variables, resulting in 56 independent clinical variables being used in the neural network predictive model. This article is protected by copyright. All rights reserved.

Deep neural network for feature selection: A deep neural network architecture consisting of six fully connected dense layers was constructed for feature selection with 56 clinical variables as inputs. Rectified linear units were chosen as activation functions and the output layer employed a sigmoid function, as binary classification was used to classify patients into the expired and survived groups. Five-fold cross validation was used to optimize model performance. Model prediction performance after fitting was used to rank the 56 features by importance from the neural network, using permutation importance methodology. 25 By shuffling single features, the error of the model was analyzed to select the features with the highest relevance. The optimal number of features necessary for classification was derived through comparing model accuracy of testing with different numbers of features. 26 Once the features were ranked and the optimal number of features was determined, the neural network architecture for classification was reduced to a simple model with two fully connected dense layers, rather than six, to prevent overfitting for prediction using top (five) clinical variables or risk stratification scores. A sigmoid function for activation in the output layer was employed.

Risk stratification score: The top 5 clinical variables derived from the neural networks were chosen to compute the risk score for mortality. Locally weighted smoothing (LOESS) 27 was used to plot the probability of mortality for each clinical variable. Different probabilities were evaluated and thresholds derived from 20% probability of mortality was found to achieve a balanced sample distribution across risk scores. Each of the 5 clinical variables had equal weight. The risk score ranged from 0 to 5.

Comparison with other indices: Performance of our deep neural network model and risk score model to predict mortality was compared with those of the pneumonia severity index (PSI), 28, 29 CURB-65 pneumonia severity score, and COVID-19 severity score. PSI (ranging from -10 to 285) is used to calculate the probability of morbidity and mortality. PSI requires a large set of input parameters. CURB-65 (ranging from 0 to 5) composed of a point system based on an exhibition of Confusion, Urea nitrogen level in the blood, Respiratory rate, Blood pressure, and age over 65 (CURB-65). 30,31 COVID-19 severity score (ranging from 0-3 as mild, moderate, severe, critical rating) was computed according to the fifth edition of the diagnosis and treatment plan issued by the Chinese National Health Commission as: a) mild: minimal clinical symptoms, no radiological pneumonia signs; b) moderate: fever, respiratory tract symptoms, signs of radiological pneumonia findings; c) severe: respiratory distress (respiratory rate ≥ 30 bpm), SaO2 ≤ 93% at resting state, or PaO2/FiO2 ≤ 300 mmHg; and d) critical: respiratory failure requiring mechanical ventilation, shock, or other organ failure requiring ICU treatment.

Statistical analysis and performance evaluation: Categorical variables described as frequencies and percentages were compared using χ 2 test. Continuous variables presented as medians and interquartile ranges (IQR) were compared using Mann-Whitney U tests. Statistical analyses were performed in SPSS v26. For performance evaluation, data were split 85% for training and 15% for testing. All prediction performance was evaluated by the area under the curve (AUC) of the receiver operating characteristic (ROC) curve for the test dataset. The average ROC curve and AUC were obtained with five runs.

This cohort consisted of 220 patients with confirmed COVID- 19 p<0.001). There were more male (66.7%) patients who died than female, and fewer male (47.9%) patients survived than female, but the sex variable as a whole was not significantly different between group in this cohort (p>0.05).

Sputum, dyspnea, and diarrhea symptoms were significantly different between groups (p<0.05). There were no significant differences in comorbidities between groups (p>0.05). For vitals, O 2 saturation, PaO 2 , oxygen index, and respiratory rate were significantly different between the survived and expired groups (p<0.05). Lab chemistry (creatinine clearance rate, lactate dehydrogenase, direct bilirubin, aspartate aminotransferase albumin, glucose, total bilirubin, blood urea nitrogen, and alanine aminotransferase) were significantly different(p<0.05), and hematological variables (neutrophil:lymphocyte ratio, neutrophil, lymphocyte, white-blood cell, and platelet counts)

were significantly different between groups as well (p<0.05). In addition, coagulation variables (Ddimer and prothrombin), immunological variables (C-reactive protein and procalcitonin), and other lab data (creatine kinase-MB, ApoA, HDL, troponin, and brain natriuretic peptide) were significantly different between groups (p<0.05).

Antibotic and steroid treatments were statistically different between groups (p<0.05). Modes of ventilation as a whole were statistically different between groups (p<0.05).

The CURB-65, PSI, COVID-19 severity scores, and length of hospital stay were significantly different between groups (p<0.05).

We first used collinearity analysis to remove highly corelated or irrelevant clinical variables, reducing the number of variables from 78 to 56 independent clinical variables. A deep neural network was used to rank the 56 independent clinical variables (Figure 1) 

Based these top 5 variables, we also constructed a risk score stratification system to predict mortality (0 to 5, lowest to highest risk). The optimal thresholds that yielded a balanced sample distribution across risk scores were: >6.7 mg/L for D-dimer, <94 for O 2 index, >10 for NE:LY, >93 mg/L for CRP, and >450 U/L for LDH. To utilize the risk stratification score in practice, each of these variables that reached the respective thresholds would add one point to the total score. Interestingly, unlike previous literature which generally cited age as an important predictor of mortality in COVID-19, 1-3,32 our model did not find age to rank amongst the top predictors of mortality in our cohort, although age was significantly different between groups. None of the comorbidities and symptoms (except diahrea) were amongst the top predictors in our cohort although some comorbidities and symptoms were significantly different between groups. These discrepancies might be because previous studies did not rank clinical features although other explanations (i.e., different patient cohorts and hospital practice or environment) are possible. While frontline physicians can readily identify patients to be at higher risk of mortality based on old age and physical distress, this and similar predictive model and advanced risk stratification tool derived based on large array of clinical variables from large patient cohorts may be helpful to objectively and robustly identify patients who ostensibly should do well but are at high risk of developing a severe disease course, complications, or poor prognosis in general. The value of such advanced risk stratification is thus to identify patients for escalated care.

It is challenging for frontline physicians to effectively utilize such large array of clinical variables in clinical decision making, especially when the disease course is not well understood and clinical decisions need to be made in time-sensitive, stressful and potentially resource-constrained environment. It is also challenging to determine the exact relationship amongst different clinical variables with respective to outcome by conventional methods. We thus developed a practical risk stratification score system. To utilize the risk stratification score in practice, each of these variables that reached the respective thresholds would accumulate one point. There were 5 possible points. The mortality rates for our risk stratification scores (0-5) were 0, 0, 6.7, 18.2, 67.7, 83.3%, respectively.

We envision such risk score to be used for risk stratification for triaging of patients with respect to ICU admission or mechanical ventilator use. These findings are significant and could have useful clinical applications.

Another novel finding is that prediction based on the 5 top clinical variables and the risk stratification score outperformed COVID-19 severity score, CURB-65, and PSI in predicting mortality in a head-to-head comparison. This finding is significant. A few studies have attempted to develop a predictive or risk score model to predict mortality and disease severity associated with COVID-19 infection. General risk scores used in emergency room, such as SOFA and MEWS, when applied to COVID-19 infection unfortunately lack adequate sensitivity and specificity to predict mortality associated with COVID-19 infection. 9,10 Lu et al. created a three-tiered risk score based on only two variables, age and CRP thresholds, to determine mortality. 33 Ji et al. used logistic regression and identified comorbidities, age, lymphocyte and LDH to be predictors of mortality but did not develop a risk score. 34 Xie et al. reported age, lymphocyte count, LDH and SpO 2 to be independent predictors of mortality but did not develop a risk score. 35 Jiang et al. used supervised learning (not deep learning) and found mildly elevated alanine aminotransferase, myalgias, and hemoglobin at presentation to be predictive of severe ARDS of COVID-19 with 70% to 80% accuracy. 36 This study had small and non-uniform clinical variables from different hospitals. Ji et al. predicted stable versus progressive COVID-19 patients (n=208) based on whether their conditions worsened during hospitalization. 37 They reported comorbidity, older age, lower lymphocyte and higher lactate dehydrogenase at presentation to be independent high-risk factors for COVID-19 progression. A nomogram of these 4 factors yielded a concordance index of 0.86. Hu et al. studied 105 patients to predict mortality using only demographic and vitals without laboratory tests. 38 They found an optimal cut-off of Rapid Emergency Medicine Score (≥6) had a sensitivity of 89.5%, a specificity of 69.8%.

None of these models employed internal validation using independent datasets and none of these studies compared with other models. Although some of the predictors of mortality were shared amongst these and our studies, there were also differences. These differences could be due to different outcome measures being investigated (mortality, ARDS, and disease severity), patient cohorts, different disease severity at admission, hospital environment, and analysis methods employed, among other factors. Thus, a predictive model needs to be flexible to incorporate new and local data, and new outcome variables.

Our predictive model differed from previous COVID-19 predictive models in several ways. Our approach used a deep-learning algorithm method which offers unique advantages over logistic regression or multivariate models. In typical regression models, clinical variables need to be dichotomized based on optimal cut off values using various methods typically to maximize the summation of sensitivity and specificity, 39 Finally, it is important to note that our machine learning predictive model and resultant risk stratification score system were established based on a single institutional data. This work is a first step toward clinical translation. Our predictive model and risk stratification score system need to be externally validated using multi-institutional data and/or prospective studies before clinical application can be realized. Should our tool be externally validated in due course, we envision such predictive model and risk stratification score system can be used by frontline physicians to more effectively triage COVID-19 patients.

Our study had several limitations. This is a retrospective study based on a single institution as mentioned above. This study include clinical variables only at presentation. Incorporating longitudinal clinical data should provide additional insights. Finally, it is important to note that the COVID-19 pandemic circumstance is unusual and evolving. Flow of patients (i.e., ICU) and mortality may depend on individual hospital's patient load, practice, and available resources, which also differ amongst countries.

We implemented a deep-learning neural network algorithm to identify top clinical variables and constructed a risk stratification score to predict mortality in COVID-19 patients. Our predictive model compares favorably with standard CURB-65, PSI and COVID-19 severity score. This approach has the potential to provide frontline physicians with a simple and objective tool to stratify patients based on risks so that they can triage COVID- 19 

A Novel Coronavirus from Patients with Pneumonia in China

Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

WHO. Coronavirus disease 2019 (COVID-19) Situation Report

First-wave COVID-19 transmissibility and severity in China outside Hubei after control measures, and second-wave scenario planning: a modelling impact assessment. The Lancet

Diagnostic performance of CT and RT-PCR for COVID-19: A metaanalysis

Evaluation of COVID-19 RT-qPCR test in multi-sample pools

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

Comparison of hospitalized patients with acute respiratory distress syndrome caused by COVID-19 and H1N1

Skin Reactions of N95 masks and Medial Masks among Health Care Personnel: A self-report questionnaire survey in China

Artificial intelligence, machine learning, computer-aided diagnosis, and radiomics: advances in imaging towards to precision medicine

Lifecycle Regulation of Artificial Intelligence-and Machine Learning-Based Software Devices in Medicine

A systematic review of the diagnostic accuracy of artificial intelligencebased computer programs to analyze chest x-rays for pulmonary tuberculosis

Artificial Intelligence in Cardiology

Cardiovascular disease risk prediction using automated machine learning: A prospective study of 423,604 UK Biobank participants

Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation

A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD)

Artificial intelligence versus logistic regression statistical modelling to predict cardiac complications after noncardiac surgery

AI outperforms radiologists in mammographic screening

Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD)

The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies

Multivariate Imputation by Chained Equations in R

Permutation importance: a corrected feature importance measure

Feature selection may improve deep neural networks for the bioinformatics problems

Development of scoring system for risk stratification in clinical medicine: a step-by-step tutorial

Applying a prediction rule to identify low-risk patients with community-acquired pneumonia

A prediction rule to identify low-risk patients with communityacquired pneumonia

Study of community acquired pneumonia aetiology (SCAPA) in adults admitted to hospital: implications for management guidelines

Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study

Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis

ACP risk grade: a simple mortality index for patients with confirmed or suspected severe acute respiratory syndrome coronavirus 2 disease (COVID-19) during the early stage of outbreak in Wuhan

Association of Inpatient Use of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers with Mortality Among Patients With Hypertension Hospitalized With COVID-19

Development and external validation of a prognostic multivariable model on admission for hospitalized patients with COVID-19

Towards an Artificial Intelligence Framework for Data-Driven Prediction of Coronavirus Clinical Severity

Prediction for Progression Risk in Patients with COVID-19 Pneumonia: the CALL Score

Comparing Rapid Scoring Systems in Mortality Prediction of Critically Ill Patients With Novel Coronavirus Disease

Estimation of the Youden Index and its associated cutoff point

mg/L (CRP)